Wellferon

Wellferon®

Lymphoblastoid IFN alfa-n1 Immunology A drug used for KS, hairy cell leukemia, HCV in Pts w/o active liver disease. See Interferon.
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.

Wellferon

A brand name for INTERFERON ALFA.
Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005
Mentioned in ?
References in periodicals archive ?
Complete inhibition, expressed as CI[A.sub.100], was observed for interferon [beta]-1b (Betaferon) at 5,000 IU/mL, interferon [alpha]-n3 (Alferon) at 5,000 IU/mL, interferon [alpha]-n1 (Wellferon) at 250,000 IU/mL, and human leukocyte interferon [alpha] (Multiferon) at 500,000 IU/mL.
Because the criteria for ascertaining anti-SARS-CoV activity in this screen were set at 100% inhibition of CPE, and as high doses of interferons may result in severe clinical side effects, we chose to conduct further evaluations only in the interferons that showed complete inhibition from initial screen, namely, Wellferon, Multileron, Betaleron, and Alferon.
At the lowest viral load the CI[A.sub.100] were 5 IU/mL for both interferon [beta]-1b (Betaferon) and human leukocyte interferon [alpha] (Multiferon); and 50 and 250 IU/mL for interferon [alpha]-n3 (Aileron) and interferon [alpha]-n1 (Wellferon), respectively.
Additional supply was not available for testing interferon [alpha]-n1 (Wellferon), as production of this drug has been discontinued.